Systematic review

You have full text access to this OnlineOpen article

Soy intake and risk of endocrine-related gynaecological cancer: a meta-analysis

  1. S-K Myung1,2,
  2. W Ju3,4,
  3. HJ Choi5,
  4. SC Kim3,4,
  5. The Korean Meta-Analysis (KORMA) Study Group

Article first published online: 23 SEP 2009

DOI: 10.1111/j.1471-0528.2009.02322.x

Issue

BJOG: An International Journal of Obstetrics & Gynaecology

BJOG: An International Journal of Obstetrics & Gynaecology

Volume 116, Issue 13, pages 1697–1705, December 2009

Additional Information

How to Cite

Myung, S.-K., Ju, W., Choi, H., Kim, S. and The Korean Meta-Analysis (KORMA) Study Group (2009), Soy intake and risk of endocrine-related gynaecological cancer: a meta-analysis. BJOG: An International Journal of Obstetrics & Gynaecology, 116: 1697–1705. doi: 10.1111/j.1471-0528.2009.02322.x

Author Information

  1. 1

    Center for Cancer Prevention and Detection, National Cancer Center, Goyang, Korea

  2. 2

    Center for Family and Community Health, School of Public Health, University of California, Berkeley, Berkeley, CA, USA

  3. 3

    Department of Obstetrics and Gynecology, School of Medicine, Ewha Womans University, Seoul, Korea

  4. 4

    Medical Research Institute, School of Medicine, Ewha Womans University, Seoul, Korea

  5. 5

    Department of Radiology, Asan Medical Center, Seoul, Korea

*W Ju, 911-1, Mok-dong, Yandchun-ku, 158-710, Seoul, Korea. Email goodmorning@ewha.ac.kr or S-K Myung, 111 Jungbalsan-ro, Ilsandong-gu, Goyang, Gyeonggi-do, 410-769, Korea. Email msk@ncc.re.kr

Publication History

  1. Issue published online: 11 NOV 2009
  2. Article first published online: 23 SEP 2009
  3. Accepted 7 February 2009. Published Online 23 September 2009.

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (215K)

References

  • 1
    Ukraintseva SV, Arbeev KG, Yashin AI. Epidemiology of hormone-associated cancers as a reflection of age. Adv Exp Med Biol 2008;630:57–71.
  • 2
    Parazzini F, La Vecchia C, Bocciolone L, Franceschi S. The epidemiology of endometrial cancer. Gynecol Oncol 1991;41:1–16.
  • 3
    Kaaks R, Lukanova A, Kurzer MS. Obesity, endogenous hormones, and endometrial cancer risk: a synthetic review. Cancer Epidemiol Biomarkers Prev 2002;11:1531–43.
  • 4
    Beral V, Bull D, Reeves G; Million Women Study Collaborators. Endometrial cancer and hormone-replacement therapy in the Million Women Study. Lancet 2005;365:1543–51.
  • 5
    Creasman WT. Adenocarcinoma of the uterus. In: DiSaiaPJ, CreasmanWT, editors. Clinical Gynecologic Oncology. Philadelphia: Mosby, 2007, pp 147–51.
  • 6
    Salehi F, Dunfield L, Phillips KP, Krewski D, Vanderhyden BC. Risk factors for ovarian cancer: an overview with emphasis on hormonal factors. J Toxicol Environ Health B Crit Rev 2008;11:301–21.
  • 7
    Messina MJ, Persky V, Setchell KD, Barnes S. Soy intake and cancer risk: a review of the in vitro and in vivo data. Nutr Cancer 1994;21:113–31.
  • 8
    Adlercreutz CH, Goldin BR, Gorbach SL, Höckerstedt KA, Watanabe S, Hämäläinen EK, et al. Soybean phytoestrogen intake and cancer risk. J Nutr 1995;125:757S-70S.
  • 9
    Gercel-Taylor C, Feitelson AK, Taylor DD. Inhibitory effect of genistein and daidzein on ovarian cancer cell growth. Anticancer Res 2004;24:795–800.
  • 10
    Gossner G, Choi M, Tan L, Fogoros S, Griffith KA, Kuenker M, et al. Genistein-induced apoptosis and autophagocytosis in ovarian cancer cells. Gynecol Oncol 2007;105:23–30.
  • 11
    Miksicek RJ. Estrogenic flavonoids: structural requirements for biological activity. Proc Soc Exp Biol Med 1995;208:44.
  • 12
    Kuiper GG, Carlsson B, Grandien K, Enmark E, Häggblad J, Nilsson S, et al. Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta. Endocrinology 1997;138:863–70.
  • 13
    Baker ME. Endocrine activity of plant-derived compounds: an evolutionary perspective. Proc Soc Exp Biol Med 1995;208:131–8.
  • 14
    Molteni A, Brizio-Molteni L, Persky V. In vitro hormonal effects of soybean isoflavones. J Nutr 1995;125:751S–6S.
  • 15
    Fitzpatrick LA. Selective estrogen receptor modulators and phytoestrogens: new therapies for the postmenopausal women. Mayo Clinic Proc 1999;74:601–7.
  • 16
    Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med 2002;21:1539–58.
    Direct Link:
  • 17
    DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986;7:177–88.
  • 18
    McCann SE, Moysich KB, Mettlin C. Intakes of selected nutrients and food groups and risk of ovarian cancer. Nutr Cancer 2001;39:19–28.
  • 19
    McCann SE, Freudenheim JL, Marshall JR, Graham S. Risk of human ovarian cancer is related to dietary intake of selected nutrients, phytochemicals and food groups. J Nutr 2003;133:1937–42.
  • 20
    Greenlee H, White E, Patterson RE, Kristal AR. Supplement use among cancer survivors in the Vitamins and Lifestyle (VITAL) study cohort. J Altern Complement Med 2004;10:660–6.
  • 21
    Webb PM, Purdie DM, Bain CJ, Green AC. Alcohol, wine, and risk of epithelial ovarian cancer. Cancer Epidemiol Biomarkers Prev 2004;13:592–9.
  • 22
    Xu WH, Zheng W, Xiang YB, Ruan ZX, Cheng JR, Dai Q, et al. Increasing intake of soya foods among Chinese women was associated with decreasing risks of endometrial cancer. Evid Based Obstet Gynecol 2005;7:44–5.
  • 23
    Xu WH, Zheng W, Xiang YB, Ruan ZX, Cheng JR, Dai Q, et al. Soya food intake and risk of endometrial cancer among Chinese women in Shanghai: population based case–control study. BMJ 2004; 328:1285.
  • 24
    Deming SL, Zheng W, Xu WH, Cai Q, Ruan Z, Xiang YB, et al. UGT1A1 genetic polymorphisms, endogenous estrogen exposure, soy food intake, and endometrial cancer risk. Cancer Epidemiol Biomarkers Prev 2008;17:563–70.
  • 25
    Dai Q, Xu WH, Long JR, Courtney R, Xiang YB, Cai Q, et al. Interaction of soy and 17beta-HSD1 gene polymorphisms in the risk of endometrial cancer. Pharmacogenet Genomics 2007;17:161–7.
  • 26
    Dalvi TB, Canchola AJ, Horn-Ross PL. Dietary patterns, mediterranean diet, and endometrial cancer risk. Cancer Causes Control 2007;18:957–66.
  • 27
    Shu XO, Zheng W, Potischman N, Brinton LA, Hatch MC, Gao YT, et al. A population-based case–control study of dietary factors and endometrial cancer in Shanghai, People’s Republic of China. Am J Epidemiol 1993;137:155–65.
  • 28
    Goodman MT, Wilkens LR, Hankin JH, Lyu LC, Wu AH, Kolonel LN. Association of soy and fiber consumption with the risk of endometrial cancer. Am J Epiedemiol 1997;146:294–306.
  • 29
    Horn-Ross PL, John EM, Canchola AJ, Stewart SL, Lee MM. Phytoestrogen intake and endometrial cancer risk. J Natl Cancer Inst 2002;95:1158–64.
  • 30
    Zhang M, Xie X, Lee AH, Binns CW. Soy and isoflavone intake are associated with reduced risk of ovarian cancer in Southeast China. Nutr Cancer 2004;49:125–30.
  • 31
    Xu WH, Dai Q, Xiang YB, Long JR, Ruan ZX, Cheng JR, et al. Interaction of soy food and tea consumption with CYP19A1 genetic polymorphisms in the development of endometrial cancer. Am J Epidemiol 2007;166:1420–30.
  • 32
    Rossi M, Negri E, Lagiou P, Talamini R, Maso LD, Montella M, et al. Flavonoids and ovarian cancer risk: a case–control study in Italy. Int J Cancer 2008;123:895–8.
    Direct Link:
  • 33
    Chang ET, Lee VS, Canchola AJ, Clarke CA, Purdie DM, Reynolds P, et al. Diet and risk of ovarian cancer in the California Teachers Study Cohort. Am J Epidemiol 2007;165:802–13.
  • 34
    Sakauchi F, Khan MMH, Mori M, Kubo T, Fujino Y, Suzuki S, et al. Dietary habits and risk of ovarian cancer death in a Large-Scale Cohort Study (JACC Study) in Japan. Nutr Cancer 2007;57:138–45.
  • 35
    Kuiper GG, Enmark E, Pelto-Huikko M, Nilsson S, Gustafsson JA. Cloning of a novel receptor expressed in rat prostate and ovary. Proc Natl Acad Sci USA 1996;93:5925–30.
  • 36
    Warner M, Saji S, Gustafsson JA. The normal and malignant mammary gland: a fresh look with ER beta onboard. J Mammary Gland Biol Neoplasia 2000;5:289–94.
  • 37
    Platet N, Cathiard AM, Gleizes M, Garcia M. Estrogens and their receptors in breast cancer progression: a dual role in cancer proliferation and invasion. Crit Rev Oncol Hematol 2004;51:55–67.
  • 38
    Weihua Z, Andersson S, Cheng G, Simpson ER, Warner M, Gustafsson JA. Update on estrogen signaling. FEBS Lett 2003;546:17–24.
  • 39
    Vaya J, Tamir S. The relation between the chemical structure of flavonoids and their estrogen-like activities. Curr Med Chem 2004;11:1333–43.
  • 40
    Jarry H, Harnischfeger G, Duker E. The endocrine effects of constituents of Cimicifuga racemosa 2. In vitro binding of constituents to estrogen receptors. Planta Med 1985;51:316–9.
  • 41
    Brooks JD, Thompson LU. Mammalian lignans and genistein decrease the activities of aromatase and 17beta-hydroxysteroid dehydrogenase in MCF-7 cells. J Steroid Biochem Mol Biol 2005;94:461–7.
  • 42
    Krazeisen A, Breitling R, Möller G, Adamski J. Phytoestrogens inhibit human 17β-hydroxsteriod dehydrogenase type 5. Mol Cell Endocrinol 2001;171:151–62.
  • 43
    Brueggemeier RW, Gu X, Mobley JA, Joomprabutra S, Bhat AS, Whetstone JL. Effects of phytoestrogens and synthetic combinatorial libraries on aromatase, estrogens biosynthesis, and metabolism. Ann NY Acad Sci 2001;948:51–66.
  • 44
    Adlercreutz K, Hockerstedt C, Bannwart E, Hamalainen T, Fotsis T, Bloigu S. Association between dietary fibre, urinary excretion of lignans and isoflavonic phytoestogens, and plasma non-protein bound sex hormones in relation to breast cancer. Prog Cancer Res Ther 1998;35:409–12.
  • 45
    Fotsis T, Pepper M, Adlercreutz H, Fleischmann G, Hase T, Montesano R, et al. Genistein, a dietary-derived inhibitor of in vitro angiogenesis. Proc Natl Acad Sci USA 1993;90:2690–4.
  • 46
    Asahi KI, Ono I, Kusakabe H, Nakamura G, Isono K. Studies on differentiation inducing substances of animal cells. I. Differenol A, a differentiation inducing substance against mouse leukemia cells. J Antibiot 1981;34:919–22.
  • 47
    Akiyama T, Ishida J, Nakagawa S, Ogawara H, Watanabe S, Itoh N, et al. Genistein, a specific inhibitor of tyrosine-specific protein kinases. J Biol Chem 1987;262:5592–5.
  • 48
    Constantinous A, Kiguchi K, Huberman E. Induction of differentiation and DNA strand breakage in human HL- 60 and K-562 leukemia cells by genistein. Cancer Res 1990;50:2618–24.
  • 49
    Dampier K, Hudson EA, Howells LM, Manson MM, Walker RA, Gescher A. Differences between human breast cell lines in susceptibility towards growth inhibition by genistein. Br J Cancer 2001;85:618–24.
  • 50
    De Lemos ML. Effects of soy phytoestrogens genistein and daidzein on breast cancer growth. Ann Pharmacother 2001;35:1118–21.
View Full Article (HTML) Get PDF (215K)